Oncology
Showing 1 to 50 of 271 entries
Category | Product Name | ABC # | Size | NDC # | Manufacturer | |
---|---|---|---|---|---|---|
Oncology | Abraxane® | 10245165 | 100 mg LYO 50 mL SDV | 68817-0134-50 | Abraxis Oncology | |
Oncology | Adcetris® | 10251195 | 50 mg | 51144-0050-01 | Seattle Genetics | |
Oncology | Afinitor® | 10243472 | 2.5 mg/28 tabs | 00078-0594-51 | Novartis | |
Oncology | Afinitor® | 10239160 | 5 mg/28 tabs | 00078-0566-51 | Novartis | |
Oncology | Afinitor® | 10239840 | 7.5 mg/28 tabs | 00078-0620-51 | Novartis | |
Oncology | Afinitor® | 10240555 | 10 mg/28 tabs | 00078-0567-51 | Novartis | |
Oncology | Avastin® | 10244671 | 400 mg | 50242-0061-01 | Genentech | |
Oncology | Azacitidine | 100 mg | Generic* | |||
Oncology | Bavencio® | 10248443 | 200 mg/10 mL | 44087-3535-01 | Emd Serono | |
Oncology | Besponsa® | 10246113 | 0.9 mg SDV PF 20 mL | 00008-0100-01 | Pfizer | |
Oncology | BESREMi® | 10263074 | 500 mcg/1mL PFS | 73536-0500-01 | PharmaEssentia | |
Oncology | Bosulif® | 10244523 | 400 mg/tab 30 | 00069-0193-01 | Pfizer | |
Oncology | Brukinsa™ | 10248205 | 80 mg | 72579-0011-02 | Beigene Usa | |
Oncology | Cabometyx™ | 10248185 | 20 mg/30 tabs | 42388-0024-26 | Exelixis | |
Oncology | Cabometyx™ | 10244340 | 40 mg/30 tabs | 42388-0025-26 | Exelixis | |
Oncology | Cabometyx™ | 10245824 | 60 mg/30 tabs | 42388-0023-26 | Exelixis | |
Oncology | Calquence® | 10248476 | 100 mg cap 60 | 00310-0512-60 | AstraZeneca | |
NEW | Oncology | Camcevi™ | 10266921 | 42 mg PFS | 69448-0014-63 | Accord Biopharma |
Oncology | Copiktra | 10245667 | 25 mg/56 caps | 71779-0125-02 | Secura Bio | |
Oncology | Cosela™ | 10254596 | 20 mL IV 300 mg | 73462-0101-01 | G1 Therapeutics | |
Oncology | Cosmegen® Injectable | 10240741 | 0.5 mg | 55292-0811-55 | Recordati Rare Diseases | |
Oncology | Cotellic™ | 10244988 | 20 mg/63 tabs | 50242-0717-01 | Genentech | |
Oncology | Cyramza® | 10248901 | 100 mg/10 mL SDV | 00002-7669-01 | Eli Lilly & Co | |
Oncology | Dacogen® | 10249007 | 50 mg SDV | 59148-0046-70 | Otsuka America Pharmaceuticals | |
NEW | Oncology | Danyelza® | 10253032 | 40 mg/10 mL SDV | 73042-0201-01 | Y-mAbs Therapeutics |
Oncology | Daurismo™ | 10247260 | 100 mg/30 tabs | 00069-1531-30 | Pfizer | |
Oncology | Enhertu® | 10248180 | 100 mg SDV | 65597-0406-01 | Daiichi Sankyo Inc. | |
Oncology | Exkivity™ | 10261629 | 40 mg/120 caps | 63020-040-12 | Takeda | |
Oncology | Fotivda® | 10255520 | 0.89 mg/21 caps | 45629-0089-01 | Aveo Oncology | |
Oncology | Fotivda® | 10255521 | 1.34 mg/21 caps | 45629-0134-01 | Aveo Oncology | |
Oncology | Jemperli | 10257721 | 500 mg SDV 10 mL | 00173-0898-03 | GlaxoSmithKline | |
NEW | Oncology | Kimmtrak® | 10264691 | 100 mcg/0.5 mL SDV | 80446-0401-01 | Immunocore |
Oncology | Lenvima® | 10245152 | 8 mg cap 30 UD | 62856-0708-30 | Eisai | |
Oncology | Lorbrena® | 10247258 | 25 mg/30 tabs | 00069-0227-01 | Pfizer | |
Oncology | Lumakras™ | 10258575 | 120 mg/240 tabs | 55513-0488-24 | Amgen Inc. | |
Oncology | Lynparza® | 10246110 | 150 mg tab 120 | 00310-0679-12 | AstraZeneca | |
Oncology | Margenza™ | 10255126 | 250 mg INJ 10 mL | 74527-0022-02 | MacorGenics | |
NEW | Oncology | Opdualag™ | 10266390 | 240/80 mg/20 mL SDV | 00003-7125-11 | Bristol Myers-Squibb |
Oncology | Pepaxto® | 10255002 | 20 mg INJ 1 | 73657-0020-01 | Oncopeptides | |
Oncology | Rybrevant™ | 10258682 | 350 mg/7 mL SDV | 57894-0501-01 | JOM product | |
Oncology | Rylaze™ | 10259717 | 10 mg/3 × 0.5 mL SDV | 68727-0900-03 | Jazz Pharmaceuticals | |
Oncology | Scemblix® | 10262738 | 20 mg/60 tabs | 00078-1091-20 | Novartis | |
Oncology | Scemblix® | 10262737 | 40 mg/60 tabs | 00078-1098-20 | Novartis | |
Oncology | Tivdak™ | 10261753 | 40 mg SDV | 51144-0003-01 | Seagen | |
Oncology | Truseltiq™ | 10258867 | 50 mg DAILY DOSE PK | 72730-0506-01 | QED Therapeutics | |
Oncology | Truseltiq™ | 10258929 | 125 mg DAILY DOSE PK | 72730-0101-01 | QED Therapeutics | |
Oncology | Truseltiq™ | 10258944 | 100 mg/21 caps | 72730-0111-01 | QED Therapeutics | |
Oncology | Truseltiq™ | 10258835 | 75 mg DAILY DOSE PK | 72730-0202-01 | QED Therapeutics | |
NEW | Oncology | Vonjo™ | 10265496 | 100 mg/120 caps | 72482-0100-12 | CTI Biopharma |
Oncology | Zynlonta™ | 10257760 | 10 mg vial 1 DS | 79952-0110-01 | ADC Therapeutics |